Webinars

Machine learning-powered image analysis makes it possible to automatically and reliably quantify complex 3D cell structures.

As global regulations shift toward animal-free testing, how can researchers develop more biologically relevant in vitro models to advance drug discovery?

Explore how a rare kidney disease trial achieved faster patient enrollment with data-informed strategies and collaborative partnerships.

ChatGPT introduced the world to the power of generative AI — that same idea is helping researchers interpret vast omics datasets to uncover new therapeutic insights.

Cell-free gene synthesis removes key bottlenecks in mRNA synthesis, accelerating the development of lifesaving therapies.

DNA-based testing is emerging as a sensitive way to uncover and control a hidden threat in biomanufacturing.

Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.

Advanced analytical techniques are making it easier to detect and measure mirror-image drug molecules that can behave very differently in the body.

New cell-based screening strategies are helping to overcome key barriers in speed, scalability, and biological relevance.

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.

AI-enhanced, cloud-native solutions can help researchers address barriers to collaborative drug discovery projects.

Discover how better sample preparation can unlock improved assay accuracy and analytical results.